Third Infusion

February 8, 2016

 

ADDENDUM POST TREATMENT:

 

The patient tolerated up to 200 mg. of ketamine per hour limited by deep anesthesia. The patient had stable vital signs with no nausea, vomiting, or adverse hallucinations.

The patient's pain thresholds showed improvement associated with increased range of motion and increased strength. 

 

The patient’s clinical outcome and treatment plan was documented in a video recording. The patient was provided a copy of the pre-treatment and post-treatment videos.

 

 

 

 

PAIN THRESHOLDS NORMAL SUBJECTS

3-DAY KETAMINE TREATMENT ... MORE VIDEOS

HOME  |  MENU  |  CONTACT US

The International Research Foundation for RSD / CRPS is a
501(c)(3) (not-for-profit) organization in the United States of America.

Copyright © 2003 International Research Foundation for RSD / CRPS.
All rights reserved.
For permission to reprint any information on the website, please contact the Foundation.

Produced By: Amanda Nichols